These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38932269)

  • 1. Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients.
    Roder C; Cosgrave C; Mackie K; McNamara B; Doyle JS; Wade AJ
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leave No-One Behind: A Retrospective Study of Hepatitis C Testing and Linkage to Care for Hospital Inpatients.
    Roder C; Cosgrave C; Mackie K; Roberts SK; Hellard ME; Wade AJ; Doyle JS
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
    Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
    Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020.
    Dawe J; Wilkinson AL; Asselin J; Carter A; Pedrana A; Traeger MW; Thomas AJ; Curtis M; Cooper M; Howell J; Doyle JS; Hellard ME; Stoové M;
    Int J Drug Policy; 2022 Jun; 104():103696. PubMed ID: 35490624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.
    Bundle N; Balasegaram S; Parry S; Ullah S; Harris RJ; Ahmad K; Foster GR; Tong CY; Orkin C
    Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population.
    Merchant RC; Baird JR; Liu T; Taylor LE; Montague BT; Nirenberg TD
    Acad Emerg Med; 2014 Jul; 21(7):752-67. PubMed ID: 25125271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C testing and status among opioid substitution treatment clients in New South Wales.
    Shand FL; Day C; Rawlinson W; Degenhardt L; Martin NG; Nelson EC
    Aust N Z J Public Health; 2014 Apr; 38(2):160-4. PubMed ID: 24690055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
    Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.
    Ragan K; Pandya A; Holotnak T; Koger K; Collins N; Swain MG
    Can J Gastroenterol Hepatol; 2020; 2020():5258289. PubMed ID: 32211349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing.
    Enkelmann J; Gassowski M; Nielsen S; Wenz B; Roß S; Marcus U; Bremer V; Zimmermann R;
    Harm Reduct J; 2020 Jan; 17(1):7. PubMed ID: 31924208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and HCV testing at clinical encounters among people who inject drugs, 2013-2018-Opportunities for increased testing and prevention.
    Evans KN; Vettese T; Wortley PM; Gandhi AP; Bradley H
    J Viral Hepat; 2023 Nov; 30(11):848-858. PubMed ID: 37726974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019.
    Lee Wilkinson A; Pedrana A; Traeger MW; Asselin J; El-Hayek C; Nguyen L; Polkinghorne V; Doyle JS; Thompson AJ; Howell J; Scott N; Dimech W; Guy R; Hellard M; Stoové M;
    Epidemiol Infect; 2021 Dec; 150():e7. PubMed ID: 35249577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in inpatient and outpatient hepatitis C virus prevalence and linkage to care rates in a safety net hospital hepatitis C screening program.
    Veeramachaneni H; Park B; Blakely D; Palacio A; Darby R; Fluker SA; Lyles RH; Miller LS
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2285-2291. PubMed ID: 33724551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a Rapid Hepatitis C Virus Screening and Diagnostic Testing Program in an Urban Emergency Department.
    White DA; Anderson ES; Pfeil SK; Trivedi TK; Alter HJ
    Ann Emerg Med; 2016 Jan; 67(1):119-28. PubMed ID: 26253712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours.
    Lacey C; Ellen S; Devlin H; Wright E; Mijch A
    Australas Psychiatry; 2007 Aug; 15(4):315-9. PubMed ID: 17612885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency departments at the crossroads of intersecting epidemics (HIV, HCV, injection drug use and opioid overdose)-Estimating HCV incidence in an urban emergency department population.
    Hsieh YH; Patel AV; Loevinsohn GS; Thomas DL; Rothman RE
    J Viral Hepat; 2018 Nov; 25(11):1397-1400. PubMed ID: 29888842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department targeted screening for hepatitis C does not improve linkage to care.
    Houri I; Horowitz N; Katchman H; Weksler Y; Miller O; Deutsch L; Shibolet O
    World J Gastroenterol; 2020 Aug; 26(32):4878-4888. PubMed ID: 32921964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services.
    Traeger MW; Pedrana AE; van Santen DK; Doyle JS; Howell J; Thompson AJ; El-Hayek C; Asselin J; Polkinghorne V; Membrey D; Bramwell F; Carter A; Guy R; Stoové MA; Hellard ME;
    PLoS One; 2020; 15(6):e0235445. PubMed ID: 32603349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system.
    Gibbs D; Price O; Grebely J; Larney S; Sutherland R; Read P; Butler K; Degenhardt L; Peacock A
    Drug Alcohol Depend; 2021 Nov; 228():109050. PubMed ID: 34607193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department.
    Hsieh YH; Rothman RE; Laeyendecker OB; Kelen GD; Avornu A; Patel EU; Kim J; Irvin R; Thomas DL; Quinn TC
    Clin Infect Dis; 2016 May; 62(9):1059-65. PubMed ID: 26908800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.